Indivior PLC (LON:INDV)
798.00
+26.00 (3.37%)
Apr 25, 2025, 2:43 PM BST
Indivior Revenue
Indivior had revenue of $266.00M USD in the quarter ending March 31, 2025, a decrease of -6.34%. This brings the company's revenue in the last twelve months to $1.17B, up 4.09% year-over-year. In the year 2024, Indivior had annual revenue of $1.19B with 8.69% growth.
Revenue (ttm)
$1.17B
Revenue Growth
+4.09%
P/S Ratio
1.06
Revenue / Employee
$1.11M
Employees
1,051
Market Cap
963.14M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | 95.00M | 8.69% |
Dec 31, 2023 | 1.09B | 192.00M | 21.31% |
Dec 31, 2022 | 901.00M | 110.00M | 13.91% |
Dec 31, 2021 | 791.00M | 144.00M | 22.26% |
Dec 31, 2020 | 647.00M | -138.00M | -17.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Indivior News
- 1 day ago - A Look at Indivior's Upcoming Earnings Report - Benzinga
- 7 weeks ago - Decoding Indivior PLC (INDV): A Strategic SWOT Insight - GuruFocus
- 7 weeks ago - Two Seas Capital LP Reduces Stake in Indivior PLC - GuruFocus
- 7 weeks ago - Indivior Announces Further Changes to Board of Directors - PRNewsWire
- 2 months ago - UK's Indivior appoints Joe Ciaffoni as CEO - Reuters
- 2 months ago - Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer - PRNewsWire
- 2 months ago - Indivior gets FDA approval for label changes for Sublocade injection - Seeking Alpha
- 2 months ago - Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection - PRNewsWire